Aprea Therapeutics Inc expected to post a loss of 78 cents a share - Earnings Preview

Aprea Therapeutics

10/05/2024 12:59

* Aprea Therapeutics Inc  APRE.OQ   APRE.O  is expected
to show no
change in quarterly revenue when it reports  results on May 13
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Aprea Therapeutics Inc
is for
a loss of 78 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $16.00​, above​ its last closing price
of $5.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023              -0.77      -0.92     Missed  -19
 Sep. 30 2023  -1.16       -1.16      -0.86     Beat    26.1
 Jun. 30 2023  -1.42       -1.42      -0.87     Beat    38.9​
 Mar. 31 2023  -1.52       -1.50      -1.34     Beat    11
 ​​Dec.        -4.04       -3.08      -0.92     Beat    70.1
 31 2022                                                
 Sep. 30 2022  -9.20       -5.50      -2.40     Beat    56.4​
 Jun. 30 2022  -7.00       -7.50      -19.60    Missed  -161.3
 Jan. 1 0001   -7.60       -7.60      -7.20     Beat    5.3
 This summary was machine generated May 10 at 11:59 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)